Drug Safety

Potential Determinants of Drug-Drug Interaction Associated Dispensing in Community Pharmacies
pp. 371-378(8)
Authors: Becker, Matthijs L.; Kallewaard, Marjon; Caspers, Peter W.J.; Schalekamp, Tom; Stricker, Bruno H.C.

The WHO World Alliance for Patient Safety: A New Challenge or an Old One Neglected?
pp. 379-386(8)
Author: Edwards, I. Ralph

The Safety of Herbal Medicinal Products Derived from Echinacea Species: A Systematic Review
pp. 387-400(14)
Authors: Huntley, Alyson L.; Joanna Thompson Coon,; Ernst, Edzard

Chemotherapy-Induced Ovarian Failure: Manifestations and Management
pp. 401-416(16)
Authors: Molina, Julian R.; Barton, Debra L.; Loprinzi, Charles L.

Benefit-Risk Assessment of Irinotecan in Advanced Colorectal Cancer
pp. 417-433(17)
Author: Glimelius, Bengt

Incidence of Thrombotic Cardiovascular Events in Patients Taking Celecoxib Compared with Those Taking Rofecoxib: Interim Results from the New Zealand Intensive Medicines Monitoring Programme
pp. 435-442(8)
Authors: Harrison-Woolrych, Mira; Herbison, Peter; McLean, Rachael; Ashton, Janelle; Slattery, Jim

Retrospective Analysis of the Safety Profile of Oral Moxifloxacin in Elderly Patients Enrolled in Clinical Trials
pp. 443-452(10)
Authors: Andriole, Vincent T.; Haverstock, Daniel C.; Choudhri, Shurjeel H.

Detecting Adverse Drug Reactions on Paediatric Wards: Intensified Surveillance Versus Computerised Screening of Laboratory Values
pp. 453-464(12)
Authors: Haffner, Steffen; Nicoletta von Laue,; Wirth, Stefan; Thürmann, Petra A.